ICD-10-CM
ICD-10 code for Amyloidosis: E85.9
The ICD-10-CM index points "Amyloidosis" to E85 (Amyloidosis), a header that is not billable. When nothing more specific is documented, the billable code is E85.9, Amyloidosis, unspecified.
Source: CDC ICD-10-CM FY2027 Alphabetic Index file dated June 16, 2026. Publisher page
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Index subterms
A header groups codes and is not billed. A billable code is one you can report.
- E85.4with lung involvement, Organ-limited amyloidosis, and J99 for the manifestationBillable
- E85.2familial, Heredofamilial amyloidosis, unspecifiedBillable
- E85.2genetic, Heredofamilial amyloidosis, unspecifiedBillable
- E85.4heart, Organ-limited amyloidosis, and I43 for the manifestationBillable
- E85.3hemodialysis-associated, Secondary systemic amyloidosisBillable
- E85.81light chain (AL), Light chain (AL) amyloidosisBillable
- E85.4liver, Organ-limited amyloidosis, and K77 for the manifestationBillable
- E85.4localized, Organ-limited amyloidosisBillable
- E85.1neuropathic heredofamilial, Neuropathic heredofamilial amyloidosisBillable
- E85.0non-neuropathic heredofamilial, Non-neuropathic heredofamilial amyloidosisBillable
- E85.4organ limited, Organ-limited amyloidosisBillable
- E85.1Portuguese, Neuropathic heredofamilial amyloidosisBillable
- E85.4pulmonary, Organ-limited amyloidosis, and J99 for the manifestationBillable
- E85.3secondary systemic, Secondary systemic amyloidosisBillable
- E85.82senile systemic (SSA), Wild-type transthyretin-related (ATTR) amyloidosisBillable
- E85.4skin (lichen) (macular), Organ-limited amyloidosis, and L99 for the manifestationBillable
- E85.89specified NEC, Other amyloidosisBillable
- E85.4subglottic, Organ-limited amyloidosis, and J99 for the manifestationBillable
- E85.82wild-type transthyretin-related (ATTR), Wild-type transthyretin-related (ATTR) amyloidosisBillable
More specific codes in E85
A header groups codes and is not billed. A billable code is one you can report.
- E85AmyloidosisHeader
- E85.0Non-neuropathic heredofamilial amyloidosisBillable
- E85.1Neuropathic heredofamilial amyloidosisBillable
- E85.2Heredofamilial amyloidosis, unspecifiedBillable
- E85.3Secondary systemic amyloidosisBillable
- E85.4Organ-limited amyloidosisBillable
- E85.8Other amyloidosisHeader
- E85.81Light chain (AL) amyloidosisBillable
- E85.82Wild-type transthyretin-related (ATTR) amyloidosisBillable
- E85.89Other amyloidosisBillable
- E85.9Amyloidosis, unspecifiedBillable
Excludes2
Excludes2 means the other condition can be reported with this one when both are documented.
From E85. A note on a category applies to every code under it.
Related conditions
Related pages
- E85.9 code detailsNotes, nearby codes, CMS-HCC group
- Category E85Every code under it
- Chapter 4Endocrine, nutritional and metabolic diseases
- ICD-10 codes by conditionA to Z
- Check a list of ICD-10 codes
- Denial code CO-11Diagnosis does not support the procedure
- Denial code CO-146Diagnosis invalid for the date of service
- HCPCS Level II code lookup
Questions
What is the ICD-10 code for Amyloidosis?
The ICD-10-CM index points "Amyloidosis" to E85 (Amyloidosis), a header that is not billable. When nothing more specific is documented, the billable code is E85.9, Amyloidosis, unspecified.
Is E85.9 billable?
Yes. E85.9 is a billable code in the FY2027 ICD-10-CM file. Use a more specific code when the record documents one.
What documentation notes apply to E85.9?
The CDC tabular list gives 1 Excludes2 note (may be coded together when both are documented) for E85.9 and the categories above it. They are listed on this page.
What chapter is E85.9 in?
Chapter 4. Endocrine, nutritional and metabolic diseases.
When do ICD-10-CM codes change?
Every October 1, with the new fiscal year file. Some years add April 1 updates. This page uses the FY2027 file, effective October 1, 2026.